Analyzing features and molecular types of abdominal wall fibromas

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on aggressive fibromatosis of the abdominal wall, a fibrous tumor that is challenging to remove completely due to its invasive nature. By retrospectively analyzing patient data and molecular characteristics from previous surgeries, the study aims to explore the clinicopathological features and prognosis of this condition. Additionally, it investigates the impact of postoperative outcomes on patients' quality of life through follow-up assessments. Statistical methods will be employed to summarize and compare data, providing insights into recurrence and survival factors.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ① Surgical treatment for "invasive fibroma of abdominal wall"; ② Complete clinical data; ③ Agree to participate in the project.

Exclusion Criteria:

* ① can not cooperate with the project implementation; ② There is cognitive dysfunction; Refuse to participate in research projects.

Where it's running

• Shandong Provincial Hospital
  Jinan, Shandong, China Recruiting

Study contacts

• Study coordinator: Qiong Teng
• Email: tengqiong2021@163.com
• Phone: 18755138389

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing in-person and remote monitoring for cancer follow-up

  This study is testing whether patients with rare tumors follow their post-treatment care plans better with in-person visits from a doctor or remote check-ins with a nurse.

  Recruiting Phase 2 Centre Oscar Lambret · Amiens and 2 other locations · NCT05500391

• Tislelizumab plus chemotherapy to convert unresectable locally advanced esophageal squamous cell carcinoma to surgery

  This study will try whether adding the immune drug tislelizumab to chemotherapy can shrink tumors so people with initially unresectable locally advanced esophageal squamous cell carcinoma can become eligible for surgery.

  Recruiting Shandong Provincial Hospital · Jinan, Shandong · NCT07549100

• Cardiac MRI-based prediction tool for outcomes in dilated cardiomyopathy

  This project will test whether adding multi-parameter stress perfusion cardiac MRI to routine clinical data can better predict which people with dilated cardiomyopathy will go on to develop heart failure, arrhythmias, hospitalizations, or death.

  Recruiting Shandong Provincial Hospital · Jinan, Shandong · NCT07527715

• Short-course vs long-course radiotherapy followed by the PD-L1 drug adebrelimab plus CAPEOX before surgery for locally advanced rectal cancer

  This trial will test whether adding the PD‑L1 drug adebrelimab to either short‑course or long‑course radiotherapy plus CAPEOX chemotherapy before surgery helps patients with locally advanced, MSS rectal cancer.

  Recruiting Phase 2 Shandong Provincial Hospital · Jinan, Shandong · NCT07284992

• One-day nature-based tourism to reduce symptoms in major depressive disorder

  This project will test whether adding a one-day nature-based tourism activity to usual medication helps reduce depressive symptoms in adults with major depressive disorder.

  Recruiting Shandong Provincial Hospital · Jinan, Shandong and 1 other locations · NCT07180342

• Neoadjuvant therapy for esophageal cancer

  This study is testing a new combination of treatments for patients with advanced esophageal cancer to see if it can help shrink tumors before surgery.

  Recruiting Phase 2 Shandong Provincial Hospital · Jinan, Shandong · NCT06908382

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.